Innvoision IPO Day 3 Update: Issue Subscribed 9% as QIBs Lead Bidding, GMP in Focus
The public issue of Innovision Ltd. opened for subscription on March 10, 2026, and as of late on Day 2, it has seen only modest bidding activity with roughly 9 % subscribed overall and qualified institutional buyers (QIBs) leading the charge. Retail participation remains subdued, and the IPO window is set to close on March 12, 2026.
Despite the slow start, markets are watching closely as grey market premiums (GMPs) and institutional interest could hint at how shares might perform when they list on both the BSE and NSE on March 17, 2026. Investors and analysts are keen to see whether the final day of subscription sparks a late surge in demand.
Innovision IPO Day 3: Subscription Status, GMP, & Key Details
What is the current subscription status of the Innovision IPO?
The Innovision Ltd. IPO, a book‑built issue worth ₹322.84 crore priced between ₹521 and ₹548 per share, has seen sluggish bidding so far. As of the final day of subscription on March 12, 2026, the issue has been recorded roughly 0.12 times overall subscription. This means bids for about 7.14 lakh shares were received against nearly 61.32 lakh shares on offer.
Institutional interest stands out: the Qualified Institutional Buyer (QIB) portion is fully subscribed (1.00x). However, non‑institutional investors (NII) and retail investors remain weak with only around 0.19x and 0.07x, respectively. Overall demand has improved from Day 1’s very low figures but remains muted compared to high‑profile IPOs.
How has investor interest evolved since the IPO opened?
The IPO opened for subscription on March 10, 2026, and will close on March 12, 2026. On Day 1 (March 10), the issue saw only 0.02 times subscription, with retail participation especially thin.
By Day 2 (March 11), the figures improved slightly to around 0.12 times overall, driven by incremental bids from non‑institutional and retail investors. QIB participation has remained steady at full subscription.
This pattern suggests stronger confidence among institutions, while broader public demand is still hesitant. Retail investors may be waiting for clearer signals from subscription traction or grey market trends before committing.
What are the Grey Market Premium (GMP) trends telling us?
Grey Market Premium (GMP) reflects unofficial pricing sentiment before an IPO’s listing. For the Innovision IPO in early subscription days, GMP data has been evolving:
- On March 11, some reports showed near‑nil GMP, indicating limited expectation of a listing premium.
- Latest news suggests a rise in unofficial GMP to around 13%, which may signal investor optimism building independently of exchange subscription figures.
Keep in mind that GMP is not a regulated metric. It can fluctuate and should not replace verified exchange data for investment decisions.
What is Innovision’s business profile and financial backdrop?
According to the offer documents and public data:
- Innovision operates in manpower services, toll plaza management, and skill development training across India.
- The company has a diversified client base, serving more than 180 clients at over 1,000 locations as of January 2026.
- Financials for the six months ended 30 September 2025 show net profit of ₹3.57 crore and sales of ₹480 crore, highlighting growth, though margins remain modest amid industry cost pressures.
Brokerages differ in view, with some noting strong revenue growth and nationwide presence, while others flag thin margins and high valuation as points of caution.
Should investors apply for the Innovision IPO?
There is no clear consensus among analysts:
- Some brokerages see growth potential in diversified services and ongoing infrastructure spending, which could support the company’s long‑term earnings.
- Other analysts have suggested caution, highlighting the valuation relative to profits and weak subscription trends as reasons to be selective. Innovation in business segments or AI stock analysis tools may help shape future forecasts, but current demand is tepid.
Prospective investors should weigh subscription trends, GMP signals, and the company’s fundamentals before deciding whether to apply.
Innovision IPO: What are the key dates and next steps?
Here are the timeline highlights:
- Issue Open: March 10, 2026
- Issue Close: March 12, 2026
- Basis of Allotment: Expected March 13, 2026
- Refunds/Credits: Around March 16, 2026
- Listing Date: Tentatively March 17, 2026, on both BSE & NSE.
After the subscription closes, investors will watch the allotment and listing performance closely, especially given the mix of weak retail participation and rising GMP.
Bottom Line
The Innovision IPO has shown cautious interest so far, led by institutions. As the subscription window closes, attention now shifts to allotment and listing performance. Investors should monitor final demand and market signals before making decisions.
Frequently Asked Questions (FAQs)
As of March 12, 2026, the Innovision IPO is 9% subscribed overall, led mainly by institutional investors, while retail demand stays low.
The IPO allotment will be on March 13, 2026, refunds by March 16, and listing on BSE and NSE on March 17.
Grey market premium trends show early interest, but actual listing gains will depend on final subscription and market conditions.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
